<p>(<b>A</b>) GVHD was induced in recipient BALB/cJ mice following total body irradiation (TBI) and bone marrow transplantation (BMT) from T cell depleted (TCD) B6.SJL-<i>Ptprc</i><sup><i>a</i></sup><i>Pepc<sup>b</sup>/BoyJ</i> donors. Following C57BL/6J mouse donor lymphocyte infusions (DLI), immune cell infiltration was assessed by flow cytometry at 1 week, 2 weeks, and 3 weeks post-DLI (n=6 GVHD and n=6 BMT-only control per time point). (<b>B</b>) Control BMT-only mice do not exhibit GVHD and lack substantial macrophage (R3) or lymphocyte (R1, and R4 in Figure S4) infiltration. There is a very small CD11b<sup>+</sup>, CD45.1<sup>high</sup> monocyte population that expresses F11r in the control brain (<2%; R3, right panel). (<b>C</b>) Chi...
<p>(A) Bone marrow cells were isolated from either B6.SJL (CD45.1 allele), α7<sup>G</sup> (CD45.2 al...
There is growing clinical interest in the utilization of mesenchymal stem cells (MSCs) in the manage...
GVHD remains one of the major obstacles for clinical application of bone marrow transplantation ther...
<p>(A) Re-transplantation: In order to evaluate the effects of GvHD on BM niche, recipient mice in t...
<p>Survival after allogeneic BMT in a C57BL/6 (B6)→BALB/c mouse model (n = 15) of acute GVHD (<b>—</...
<p>Analyses were performed on day 14 after second transplantation. (A) Continuous HSCT: To evaluate ...
<p>(A) A MHC-haploidentical murine GVHD model was established by transplanting BM cells (5×10<sup>6<...
<p>C57Bl/6 mice were reconstituted with BM cells transduced with control MigR1 or <i>Nfix</i> vector...
Host antigen-presenting cells (APCs) are known to be critical for the induction of graft-versus-host...
<p>Blood chimerism was assessed by flow cytometry 8 weeks following transplantation of GFP<sup>+/-</...
In the present paper, we have investigated early pathophysiological events in graft-versus-host dise...
<p><b>A</b>) Overview of the experimental protocol. <i>HI</i>, <i>FNA</i> and <i>Tx</i> denote focal...
(a) Experimental design for the BMT experiment. The BMT mice were treated with 2 weeks of PLX5622 di...
<p>C57BL/6 mice were infected with 5*10e4 PbTg iRBC i.v.. Simultaneously, groups of mice received ei...
<p>The number of engrafted GFP<sup>+</sup>Iba-1<sup>+</sup> donor-derived phagocytes is strongly dec...
<p>(A) Bone marrow cells were isolated from either B6.SJL (CD45.1 allele), α7<sup>G</sup> (CD45.2 al...
There is growing clinical interest in the utilization of mesenchymal stem cells (MSCs) in the manage...
GVHD remains one of the major obstacles for clinical application of bone marrow transplantation ther...
<p>(A) Re-transplantation: In order to evaluate the effects of GvHD on BM niche, recipient mice in t...
<p>Survival after allogeneic BMT in a C57BL/6 (B6)→BALB/c mouse model (n = 15) of acute GVHD (<b>—</...
<p>Analyses were performed on day 14 after second transplantation. (A) Continuous HSCT: To evaluate ...
<p>(A) A MHC-haploidentical murine GVHD model was established by transplanting BM cells (5×10<sup>6<...
<p>C57Bl/6 mice were reconstituted with BM cells transduced with control MigR1 or <i>Nfix</i> vector...
Host antigen-presenting cells (APCs) are known to be critical for the induction of graft-versus-host...
<p>Blood chimerism was assessed by flow cytometry 8 weeks following transplantation of GFP<sup>+/-</...
In the present paper, we have investigated early pathophysiological events in graft-versus-host dise...
<p><b>A</b>) Overview of the experimental protocol. <i>HI</i>, <i>FNA</i> and <i>Tx</i> denote focal...
(a) Experimental design for the BMT experiment. The BMT mice were treated with 2 weeks of PLX5622 di...
<p>C57BL/6 mice were infected with 5*10e4 PbTg iRBC i.v.. Simultaneously, groups of mice received ei...
<p>The number of engrafted GFP<sup>+</sup>Iba-1<sup>+</sup> donor-derived phagocytes is strongly dec...
<p>(A) Bone marrow cells were isolated from either B6.SJL (CD45.1 allele), α7<sup>G</sup> (CD45.2 al...
There is growing clinical interest in the utilization of mesenchymal stem cells (MSCs) in the manage...
GVHD remains one of the major obstacles for clinical application of bone marrow transplantation ther...